MedPath

BREVIBLOC LIQ IV 250MG/ML

BREVIBLOC LIQ IV 250MG/ML

Discontinued
DIN Number

02053101

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

ohmeda pharmaceutical products, division of boc canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02053101
AIG Number0123418002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AB09 ESMOLOL
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ESMOLOL HYDROCHLORIDEActive
Strength: 250 MG / ML
Monograph: ESMOLOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.